"EMBRACING INTERNATIONAL ALLIANCES" SWISS BIOTECH INNOVATION ON DISPLAY AT THE BIO 2024 INTERNATIONAL CONVENTION IN SAN DIEGO JUNE 3-6, 2024

News provided by

May 22, 2024, 09:30 ET

ZURICH, May 22, 2024 /PRNewswire/ -- Swiss life science innovation will again be on display at the BIO 2024 convention in San Diego. Switzerland Global Enterprise will present 41 leading Swiss biotech stars at the SWISS BIOTECH pavilion demonstrating Switzerland's key role in the healthcare sector.

The companies presenting at this year's conference show a wide range of innovative solutions from drug discovery, leveraging AI for data analytics to clinical trial management and pharmaceutical consulting services.

The Swiss Biotech industry once more generated record revenues, driven by collaboration and licensing deals. Swiss biotech companies often successfully partner with large pharma companies and thanks to record numbers of approvals from Swissmedic, EMA, FDA, and other global regulatory authorities, product sales got a big boost. Meanwhile, public funding remains dire, private funding kept up the pace from 2023.

"With its R&D and manufacturing capacity far exceeding its own needs, Switzerland has established itself as a trusted partner in bilateral and multilateral alliances," Michael Altorfer CEO, Swiss Biotech Association.

Along with their partners, the Swiss Biotech Association, InnoSuisse and, Switzerland Global Enterprise and their representatives in the US, the Swiss Business Hub USA bring the leading-edge innovation that Switzerland is consistently recognized for to BIO 2024.

Switzerland Global Enterprise with its partner Swissnex in Boston and New York will be hosting a Swiss reception on Tuesday June 4^th from 5pm to 6:30pm at the Swiss Pavilion, booth #2111.

• AliraHealth	Alira Health provides global consulting and clinical services enabled by technology and real-world evidence.
• ariadne.ai ag	Specializes in leveraging artificial intelligence for advanced data analysis in biomedical research.
• Bacthera SA	Focuses on the manufacture of live biotherapeutic products for pharmaceutical clients.
• BioAlps Association	Acts as a life sciences cluster promoting networking and collaboration in the BioAlps community.
• Bioengineering AG	Provides solutions in bioprocess engineering, ranging from development to production scale.
• Biopôle SA	Operates a life sciences campus that supports innovation and development in the healthcare and biotech sectors.
• BioVersys AG	Engages in the research and development of drugs that address antimicrobial resistance.
• Business Location Switzerland	Promotes Switzerland as a prime location for business and investment.
• DiNABIOS a DiNAQOR Group Company	Specializes in innovative therapies for patients with genetic heart diseases.
• EPIC Suisse Property Management GmbH	Offers comprehensive property management services across Switzerland.
• InSphero AG	Develops and produces 3D microtissues for drug discovery and toxicity testing.
• Kisco Pharma Outsourcing Solutions	Provides outsourcing solutions for pharmaceutical manufacturing and distribution.
• KPMG	Offers audit, tax, and advisory services to help organizations
• Molecular Partners AG	Develops a new class of custom-built protein therapeutics known as DARPin® molecules.
• Novigenix	Focuses on developing and commercializing blood tests for early cancer detection and precision medicine.
• Obaris AG	Specializes in the development and commercialization of orthopedic and surgical implants.
• OM Pharma	Engages in the research, development, and marketing of medicines in respiratory and vascular diseases.
• PDC Therapeutics	Focuses on developing precision drugs for the treatment of severe and rare diseases.
• Superlab Suisse AG	Provides high-tech laboratory services and research facilities for life sciences companies.
• Tigermed Swiss SA	Offers clinical trial management and pharmaceutical consulting services.
• Venture Valuation Inc.	Specializes in the assessment and valuation of growth companies in the life sciences and technology sectors.
• Amphilix	Focuses on innovative technologies for biopharmaceutical development and production.
• Cellestia Biotech AG	Specializes in developing targeted therapies for cancer and other severe diseases based on modulating gene expression.
• Cellvie	Dedicated to advancing mitochondrial transplantation therapy to treat acute and chronic degenerative diseases.
• FluoSphera	Provides high-throughput screening services using innovative fluorescence-based technologies.
• Nagi Bioscience	Develops the first Organism-on-Chip technology for automated and ethical testing of drugs and chemicals.
• REM Analytics SA	Specializes in microbiome analytics and solutions for healthcare and agricultural applications.
• Scailyte	Uses single-cell technologies and AI-driven data analysis to discover biomarkers and advance precision medicine.
• Synendos Therapeutics AG	Focuses on the development of breakthrough therapies for the treatment of central nervous system disorders.
• Vandria	Offers digital solutions to enhance the efficiency and effectiveness of healthcare and medical management.
• Alpha Onco	Engages in the development of innovative oncology treatments.
• BioArk	Provides infrastructure and support for startups and established companies in the life sciences sector.
• Ceidos SA	Specializes in virtual reality solutions, primarily for therapeutic and rehabilitation applications.
• Curio Biotech SA	Focuses on developing novel treatments based on cell secretome for regenerative medicine.
• Excellgene	Produces biopharmaceuticals using advanced cell line engineering and protein production technologies.
• Immunskills	Offers workshops and training in immunotherapy and biological production.
• Novochizol SA	Develops chitosan-based formulations to enhance the delivery of biopharmaceuticals.
• Orio Therapeutics	Specializes in developing therapies for respiratory diseases.
• SETI / Canton VS	Supports economic development in Valais, particularly in the sectors of technology, education, and innovation.
• Stämm Biotech	Works on bioprocesses that utilize human stem cells for regenerative medicine.
• Swiss Biotech Center	Provides laboratory services, R&D, and consulting to foster innovation in biotechnology.
• ten23 health Valais Ltd.	Offers services in drug development and manufacturing, with a focus on sustainable practices.

The SWISS BIOTECH companies will be available for media and partner interviews the entire week.

www.s-ge.com

About Switzerland Global Enterprise
Switzerland Global Enterprise (S-GE) is the official Swiss organization for export and investment promotion with around 200 employees at locations throughout Switzerland and overseas. S-GE supports Swiss SMEs in their international business and helps innovative foreign companies to settle in Switzerland. In doing so, we rely on a unique network of national and international partners. This allows us to create added value for our customers and prosperity for Switzerland. As a non-profit organization, we provide a public service for our clients on behalf of the Swiss Confederation (State Secretariat for Economic Affairs SECO) and the cantons. We operate our 27 offices, the so-called Swiss Business Hubs, and Trade Points, in 31 countries jointly with the Federal Department of Foreign Affairs (FDFA). Thanks to our global network of partners, we also support our customers in many other countries.

SOURCE Swiss Business Hub USA